| Location: | Manchester |
|---|---|
| Salary: | 2003 Consultant Scale |
| Hours: | Full Time |
| Contract Type: | Permanent |
| Placed On: | 19th November 2025 |
|---|---|
| Closes: | 27th November 2025 |
| Job Ref: | BMH-030236 |
This post is jointly funded by The University of Manchester and The Christie NHS Foundation Trust. It is a full-time post with 10 programmed activities (PAs) with 5 research and 5 clinical PAs. The final job plan will be dependent on the precise interests and qualifications of the successful candidate.
The appointee will be based at The Christie NHS Foundation Trust and will provide consultant level care for patients with Hepato-pancreatico-biliary (HPB) and Neuroendocrine neoplasms (NENs). This includes providing patient review through the outpatient clinics and day case units (as appropriate), where Systemic Anti-Cancer Therapy Treatments are delivered, as well as inpatient care on the main adult oncology wards. The inpatient workload is supported by Consultant Acute Physicians who work in the Oncology Assessment Unit and the consultant providing Acute Oncology input to the Oncology base wards.
There are four consultants currently working in the HPB (composed of primary liver cancer (hepatocellular carcinoma), pancreas cancer, biliary tract cancers (cholangiocarcinoma and gallbladder cancer)) and NEN disease group; Dr Richard Hubner, Dr Mairéad McNamara, Dr Victoria Foy and Dr Nadina Tinsley. The group has a very active clinical research programme (predominantly phase II/III), with close links to basic research laboratories in the Cancer Research United Kingdom (UK) Manchester Institute. Approximately 500 new patients are seen each year (80% with advanced/metastatic disease), and approximately 23% of all these patients are entered into clinical trials. In addition, The Christie has an international reputation in the treatment of NENs (accredited as a Centre of Excellence by the European NET Society (ENETS), initially in 2011). The HPB/NEN disease group is supported by clinical research fellows, a specialist registrar, research nurses, clinical nurse specialists, nurse clinicians, patient coordinators, general practitioners with a specialist interest in oncology and clinical trials co-ordinators.
Trial activity is embedded within clinical service activity across all disease groups at The Christie and the post holder will be expected to maintain existing research and trial activity within the disease group, working with colleagues from Research and Innovation.
Consultants in the department of Medical Oncology share in an on-call rota that involves a commitment to a full week of call in every twenty weeks. This covers the Specialist Registrar who is second on-call.
Our University is positive about flexible working – you can find out more here
Hybrid working arrangements may be considered.
Please note that we are unable to respond to enquiries, accept CVs or applications from Recruitment Agencies.
Any recruitment enquiries from recruitment agencies should be directed to People.Recruitment@manchester.ac.uk.
Any CV’s submitted by a recruitment agency will be considered a gift.
Please note this role is not eligible for sponsorship under the Skilled Worker route of the Points Based System. Candidates will need to be able to demonstrate their right to work in the UK in order to be eligible to take up the post.
Enquiries about the vacancy, shortlisting and interviews:
Name: Stephen Taylor
Email: stephen.taylor@manchester.ac.uk
General enquiries:
Email: People.recruitment@manchester.ac.uk
Technical support:
https://jobseekersupport.jobtrain.co.uk/support/home
This vacancy will close for applications at midnight on the closing date.
Type / Role:
Subject Area(s):
Location(s):